Howard Hughes Medical Institute’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-217
Closed -$9.46K 195
2025
Q4
$9.46K Hold
217
0.01% 222
2025
Q3
$9.77K Hold
217
0.01% 221
2025
Q2
$9.42K Buy
+217
New +$9.66K ﹤0.01% 212
2014
Q4
Sell
-52,342
Closed -$1.27M 179
2014
Q3
$1.27M Buy
52,342
+35,676
+214% +$835K 0.28% 48
2014
Q2
$434K Buy
+16,666
New +$425K 0.07% 63

Other funds holding EXC

Howard Hughes Medical Institute's EXC Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Exelon (EXC) in Q1 2026, closing a stake of 217 shares — an estimated $9.46K sold.

Howard Hughes Medical Institute first reported a position in EXC in Q2 2014 and held it in 5 quarters. The position peaked at $1.27M in Q3 2014. 1,278 funds tracked by Wall St. Rank hold EXC as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Exelon position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 217 Exelon shares in Q1 2026, an estimated $9.46K.
  • Howard Hughes Medical Institute first reported a position in Exelon in Q2 2014 and held it in 5 quarters.
  • Howard Hughes Medical Institute's Exelon position peaked at $1.27M in Q3 2014.
  • 1,278 funds tracked by Wall St. Rank held Exelon as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.